Johnson & Johnson Shuts Insulin Pump Business, Inks Other Deals
Healthcare giant Johnson & Johnson cut costs by laying off 297 staffers tied to its insulin pump business, while also buying a German surgical software company and inking a deal with biotech company targeting hepatitis B treatments.
Alcobra shares plummet as ADHD drug fails
Alcobra has plans to restore shareholder value, but it's unclear what that plan will entail.
Corbus Pharma bear thesis is alive and well
The imbalances in patient baseline characteristics provided an assist to Corbus' resunab treatment response and undermines the credibility of the trial results, a source says.
Alcobra (ADHD) Stock Sliding, Downgraded After FDA Clinical Hold
Alcobra (ADHD) stock rating was reduced to 'neutral' at Piper Jaffray on Friday.
Alcobra (adhd) stock tumbles on fda clinical hold, cantor remains bullish
Alcobra (ADHD) announced late yesterday that the FDA has placed a clinical hold on its new drug applications for MDX for ADHD treatment.
Stock Market Today - 6/29: Stocks End Mixed As Recession Concerns Mount
Stocks ended mixed Wednesday as growth bets gave way to recession fears.
Should I Buy a House Now? (It's Personal and Complicated)
Mortgage rates are up and some markets have cooled down, but the reality is that the decision is very personal.
Crypto Crash Exposes Robinhood and Coinbase To Predators
A year can be a lifetime in the cryptocurrency world as major players are reeling from heavy losses.
Micron Earnings Preview: Will Critical Support Hold?
Micron is set to report earnings on Thursday after the close, but the stock sits on critical support. Will it hold or will it fold?